Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Analysis

Moving mountains: balancing safety and speed in drug development

The speedy review of urgently needed medicines is a key objective of any drug regulatory body, as is maintaining high safety standards. But what is the right balance between the two, and what can we learn from major public health crises and the practices of the US FDA, the fastest of the world’s premier drug regulators?

Go Top